Article

IKA Keratoconus Symposium 2023: Strategies for early diagnosis

At the IKA Keratoconus Symposium, Justin Schweitzer, OD, FAAO, presented on establishing the keratoconus diagnosis alongside Kourtney Houser, MD.

Video transcript

Justin Schweitzer, OD, FAAO:
Hi, my name is Justin Schweitzer. I'm an optometrist at Vance Thompson Vision in Sioux Falls, South Dakota, and I'm really excited to be here at the IKA Keratoconus Symposium. I'm doing a lecture with Dr. Kourtney Houser on early diagnosis of keratoconus.

It can be one of the most challenging things that we face as eye care providers, which is trying to identify keratoconus early in the disease process. It's important to identify it early in the disease process because we have ways to obviously slow it down, to stop it with corneal cross-linking now available. The problem is if we don't catch it early, and it progresses, that's where our patients really start to struggle from a quality of life standpoint, and into the future for themselves.

Some of the things that we touched on and how to identify it early—still the standard of care being tomography—but looking at changes in astigmatism over time, looking at changes in refractive error, looking at topographical changes as well. We talked about utilizing genetics to help assess the risk of our patients to maybe watch them closer, to avoid doing refractive surgery on those patients. We talked a little bit about corneal biomechanics as well and the role that that can play in diagnosing our patients earlier in the disease process.

It was a lot of fun going through this lecture with Kourtney, and we hope that we were able to provide some clinical relevant pearls that you can take to your clinics on Monday morning. It was an honor to be here at the IKA 1st Annual Keratoconus Symposium. I hope to see you all soon.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.